SNDX - Syndax Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,1081,220627
Cost of Revenue---
Gross Profit2,1081,220627
Operating Expenses
Research Development48,20131,6659,549
Selling General and Administrative15,86113,32111,591
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-61,954-43,766-20,513
Income from Continuing Operations
Total Other Income/Expenses Net-269-1,662-2,192
Earnings Before Interest and Taxes-60,802-44,472-24,119
Interest Expense---
Income Before Tax-60,802-44,472-24,119
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-60,802-44,472-24,119
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-60,802-44,472-24,119
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-60,802-47,070-103,845